Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Lipocine Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- 0 vs. Q2 2022
- Shares held
- 10.8M
- −1.12M (−9.4%) vs. Q2 2022
- Total value
- $4.85M
- −$4.69M (−49.1%) vs. Q2 2022
- New holders
- 7
- 5 more added
- Sold out
- 7
- 10 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $24.9M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.44M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.46M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $3.17M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $16.2M |
| Q4 2021 | 39 | $10.5M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 3,797,282 | $1.71M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,454,958 | $655.0K | 0.00% | −158,036−9.8% | Reduced |
| Wealth Effects LLC | 1,215,834 | $547.0K | 0.34% | −264,500−17.9% | Reduced |
| Geode Capital Management, LLC | 832,079 | $374.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 425,664 | $192.0K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 325,159 | $146.0K | 0.00% | −133,519−29.1% | Reduced |
| State Street Corp | 316,633 | $142.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 295,416 | $133.0K | 0.00% | +295,416 | New |
| Kestra Advisory Services, LLC | 276,300 | $124.0K | 0.00% | +1,500+0.5% | Added |
| Two Sigma Advisers, LP | 209,600 | $94.0K | 0.00% | −100,000−32.3% | Reduced |
| Renaissance Technologies LLC | 199,400 | $90.0K | 0.00% | +118,394+146.2% | Added |
| Price T Rowe Associates Inc | 184,662 | $84.0K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 159,111 | $72.0K | 0.00% | −150,000−48.5% | Reduced |
| Northern Trust Corp | 160,603 | $72.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 93,411 | $42.0K | 0.00% | +93,411 | New |
| Acadian Asset Management LLC | 85,070 | $37.0K | 0.00% | 00.0% | Unchanged |
| MML Investors Services, LLC | 77,000 | $35.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 73,082 | $33.0K | 0.00% | −126,984−63.5% | Reduced |
| RSM US Wealth Management LLC | 65,212 | $29.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 62,750 | $28.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 52,960 | $24.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 50,000 | $23.0K | 0.00% | 00.0% | Unchanged |
| Aaron Wealth Advisors | 45,045 | $20.0K | 0.00% | −100,000−68.9% | Reduced |
| Ameriprise Financial Inc | 44,000 | $20.0K | 0.00% | −22,500−33.8% | Reduced |
| Morgan Stanley | 35,537 | $16.0K | 0.00% | −21,450−37.6% | Reduced |
| Susquehanna International Group, LLP | 35,005 | $16.0K | 0.00% | +2,920+9.1% | Added |
| Jane Street Group, LLC | 31,532 | $14.0K | 0.00% | +4,656+17.3% | Added |
| Merit Financial Group, LLC | 29,901 | $13.0K | 0.00% | +10.0% | Added |
| EP Wealth Advisors, LLC | 26,637 | $12.0K | 0.00% | +26,637 | New |
| Moloney Securities Asset Management, LLC | 22,500 | $10.0K | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 17,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Kestra Private Wealth Services, LLC | 14,461 | $7.00K | 0.00% | +14,461 | New |
| Mariner, LLC | 13,675 | $6.00K | 0.00% | +13,675 | New |
| Cutler Group LP | 13,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Snowden Capital Advisors LLC | 12,578 | $5.00K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 10,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,897 | $4.00K | 0.00% | +9,897 | New |
| JPMorgan Chase & Co | 3,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Benjamin F. Edwards & Company, Inc. | 1,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,150 | $1.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 1,407 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 588 | $0 | 0.00% | −3,004−83.6% | Reduced |
| Bank of America Corp | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 101 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 210 | $0 | 0.00% | +210 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −440,658−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −74,400−100.0% | Sold out |
| Carson Advisory Inc. | 0 | $0 | 0.00% | −52,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −25,952−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −20,152−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −10,902−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −108−100.0% | Sold out |